Trichomonas vaginalis infection and human immunodeficiency virus acquisition in African women

Journal of Infectious Diseases

Volumn 197, Issue 4, 2008, Pages 548-554

  Van Der Pol, Barbara ^a,b,h   Kwok, Cynthia ^c   Pierre Louis, Bosny ^c   Rinaldi, Anne ^c   Salata, Robert A ^d   Chen, Pai Lien ^c   Van De Wijgert, Janneke ^e   Mmiro, Francis ^f   Mugerwa, Roy ^f   Chipato, Tsungai ^g   Morrison, Charles S ^c  

^a INDIANA UNIVERSITY   (United States)

^b Marion County Health Department   (United States)

^c FAMILY HEALTH INTERNATIONAL   (United States)

^d CASE WESTERN RESERVE UNIVERSITY   (United States)

^e UNIVERSITY OF AMSTERDAM   (Netherlands)

^f MAKERERE UNIVERSITY   (Uganda)

^g UNIV OF ZIMBABWE MEDICAL SCHOOL   (Zimbabwe)

^h NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADULT; AFRICA; ARTICLE; BEHAVIOR; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEMOGRAPHY; DISEASE DURATION; FEMALE; FOLLOW UP; HERPES SIMPLEX VIRUS 2; HIGH RISK PATIENT; HORMONAL CONTRACEPTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PATIENT REFERRAL; POLYMERASE CHAIN REACTION; PREDICTION; PREVALENCE; PRIORITY JOURNAL; SEROCONVERSION; SEXUALITY; SEXUALLY TRANSMITTED DISEASE; STATISTICAL SIGNIFICANCE; TRICHOMONAS VAGINALIS; TRICHOMONIASIS; UGANDA; ZIMBABWE;

ADOLESCENT; ADULT; AMBULATORY CARE FACILITIES; ANIMALS; CASE-CONTROL STUDIES; FEMALE; HIV INFECTIONS; HIV SEROPOSITIVITY; HIV-1; HUMANS; LONGITUDINAL STUDIES; PREVALENCE; RISK FACTORS; TRICHOMONAS VAGINALIS; TRICHOMONAS VAGINITIS; UGANDA; ZIMBABWE;

EID: 40049085252     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/526496     Document Type: Article

References (20)

1. Buve A, Weiss HA, Laga M, et al. The epidemiology of trichomoniasis in women in four African cities. AIDS 2001; 15(Suppl 4):S89-96.
2. Cohen CR, Plummer FA, Mugo N, et al. Increased interleukin-10 in the endocervical secretions of women with non-ulcerative sexually transmitted diseases: a mechanism for enhanced HIV-1 transmission? AIDS 1999; 13:327-32.
3. Guenthner PC, Secor WE, Dezzutti CS. Trichomonas vaginalis-induced epithelial monolayer disruption and human immunodeficiency virus type 1 (HIV-1) replication: implications for sexual transmission of HIV-1. Infect Immun 2005; 73:4155-60.
4. Moodley P, Wilkinson D, Connolly C, Moodley J, Sturm AW. Trichomonas vaginalis is associated with pelvic inflammatory disease in women infected with human immunodeficiency virus. Clin Infect Dis 2002; 34:519-22.
5. Wang CC, McClelland RS, Reilly M, et al. The effect of treatment of vaginal infections on shedding of human immunodeficiency virus type 1. J Infect Dis 2001; 183:1017-22.
6. Price MA, Zimba D, Hoffman IF, et al. Addition of treatment for trichomoniasis to syndromic management of urethritis in Malawi: a randomized clinical trial. Sex Transm Dis 2003; 30:516-22.
7. Laga M, Alary M, Nzila N, et al. Condom promotion, sexually transmitted diseases treatment, and declining incidence of HIV-1 infection in female Zairian sex workers. Lancet 1994; 344:246-8.
8. Laga M, Manoka A, Kivuvu M, et al. Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study. AIDS 1993; 7:95-102.
9. Rottingen JA, Cameron DW, Garnett GP. A systematic review of the epidemiologic interactions between classic sexually transmitted diseases and HIV: how much is really known? Sex Transm Dis 2001; 28:579-97.
10. Sexton J, Garnett GP, Rottingen J. Meta-analysis and metaregression in interpreting study variability in the impact of sexually transmitted diseases on susceptibility to HIV infection. Sex Transm Dis 2005; 32:351-7.
11. McClelland RS, Sangare L, Hassan WM, et al. Infection with Trichomonas vaginalis increases the risk of HIV-1 acquisition. J Infect Dis 2007; 195:698-702.
12. Boily M, Anderson R. Human immunodeficiency virus transmission and the role of other sexually transmitted diseases: measures of association and study design. Sex Transm Dis 1996; 23:312-32.
13. Korenromp E, de Vlas S, Nagelkerke N, Habbema J. Estimating the magnitude of STD cofactor effect on HIV transmission: how well can it be done? Sex Transm Dis 2001; 28:613-23.
14. Morrison CS, Richardson BA, Mmiro F, et al. Hormonal contraception and the risk of HIV acquisition. AIDS 2007; 21:85-95.
15. Van Der Pol B, Martin DH, Schachter J, et al. Enhancing the specificity of the COBAS AMPLICOR CT/NG test for Neisseria gonorrhoeae by retesting specimens with equivocal results. J Clin Microbiol 2001; 39:3092-8.
16. Van Der Pol B, Kraft CS, Williams JA. Use of an adaptation of a commercially available PCR assay aimed at diagnosis of chlamydia and gonorrhea to detect Trichomonas vaginalis in urogenital specimens. J Clin Microbiol 2006; 44:366-73.
17. Rothman K, Greenland S. Matching. In: Modern epidemiology. 2nd ed. Philadelphia, PA: Lippincott, Williams & Wilkins, 1998:147-61.
18. Van Der Pol B, Williams JA, Orr DP, Batteiger BE, Fortenberry JD. Prevalence, incidence, natural history, and response to treatment of Trichomonas vaginalis infection among adolescent women. J Infect Dis 2005; 192:2039-44.
19. Centers for Disease Control and Prevention. HIV prevention through early detection and treatment of other sexually transmitted diseases - United States: recommendations of the Advisory Committee for HIV and STD Prevention. MMWR Recomm Rep 1998; 47(RR-12):1-24.
20. Sorvillo F, Smith L, Kerndt P, Ash L. Trichomonas vaginalis, HIV, and African-Americans. Emerg Infect Dis 2001; 7:927-32.